Smokers’ drug, mental ills linked
From Times Wire Reports
Government regulators said the connection between Pfizer’s anti-smoking drug Chantix and serious psychiatric problems is “increasingly likely.”
The Food and Drug Administration said it has received reports of 37 suicides and more than 400 of suicidal behavior in connection with the drug.
In November, the agency began investigating reports of depression, agitation and suicidal behavior among patients taking the popular twice-daily pill.
More to Read
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.